Krish S. Krishnan - Sep 12, 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Signature
/s/ Krish S. Krishnan
Stock symbol
KRYS
Transactions as of
Sep 12, 2024
Transactions value $
-$9,888,276
Form type
4
Date filed
9/13/2024, 05:44 PM
Previous filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRYS Common Stock Sale -$772K -3.96K -0.25% $195.16 1.58M Sep 12, 2024 Direct F1, F2
transaction KRYS Common Stock Sale -$1.26M -6.46K -0.41% $195.72 1.58M Sep 12, 2024 Direct F1, F3
transaction KRYS Common Stock Sale -$334K -1.7K -0.11% $197.04 1.58M Sep 12, 2024 Direct F1, F4
transaction KRYS Common Stock Sale -$413K -2.09K -0.13% $198.08 1.57M Sep 12, 2024 Direct F1, F5
transaction KRYS Common Stock Sale -$797K -4.01K -0.25% $198.93 1.57M Sep 12, 2024 Direct F1, F6
transaction KRYS Common Stock Sale -$721K -3.6K -0.23% $200.15 1.57M Sep 12, 2024 Direct F1, F7
transaction KRYS Common Stock Sale -$481K -2.4K -0.15% $200.98 1.56M Sep 12, 2024 Direct F1, F8
transaction KRYS Common Stock Sale -$161K -800 -0.05% $201.81 1.56M Sep 12, 2024 Direct F1, F9
transaction KRYS Common Stock Sale -$1.66M -8.5K -0.56% $195.43 1.52M Sep 12, 2024 By Spouse F10, F11, F12, F13
transaction KRYS Common Stock Sale -$535K -2.73K -0.18% $196.07 1.51M Sep 12, 2024 By Spouse F10, F11, F13, F14
transaction KRYS Common Stock Sale -$274K -1.39K -0.09% $197.55 1.51M Sep 12, 2024 By Spouse F10, F11, F13, F15
transaction KRYS Common Stock Sale -$673K -3.39K -0.22% $198.43 1.51M Sep 12, 2024 By Spouse F10, F11, F13, F16
transaction KRYS Common Stock Sale -$587K -2.95K -0.2% $199.22 1.51M Sep 12, 2024 By Spouse F10, F11, F13, F17
transaction KRYS Common Stock Sale -$834K -4.16K -0.28% $200.41 1.5M Sep 12, 2024 By Spouse F10, F11, F13, F18
transaction KRYS Common Stock Sale -$382K -1.9K -0.13% $201.52 1.5M Sep 12, 2024 By Spouse F10, F11, F13, F19
holding KRYS Common Stock 90K Sep 12, 2024 By Krishnan Spousal Trust
holding KRYS Common Stock 50K Sep 12, 2024 By Krishnan Family Trust F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024. The Rule 10b5-1 trading plan started on September 12, 2024 and will terminate on September 13, 2025 and contemplates quarterly sales of 25,000 shares of common stock with a limit price of $150.00 per share.
F2 The transaction was executed in multiple trades ranging from $194.4500 to $195.4300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The transaction was executed in multiple trades ranging from $195.4500 to $196.2600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 The transaction was executed in multiple trades ranging from $196.4900 to $197.4600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F5 The transaction was executed in multiple trades ranging from $197.5500 to $198.5200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F6 The transaction was executed in multiple trades ranging from $198.5500 to $199.4300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F7 The transaction was executed in multiple trades ranging from $199.5900 to $200.5700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F8 The transaction was executed in multiple trades ranging from $200.6200 to $201.5900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F9 The transaction was executed in multiple trades ranging from $201.6900 to $201.9500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F10 The sales reported were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse, Suma M. Krishnan, on June 13, 2024. The Rule 10b5-1 trading plan started on September 12, 2024 and will terminate on September 13, 2025 and contemplates quarterly sales of 25,000 shares of common stock with a limit price of $150.00 per share.
F11 These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Suma M. Krishnan.
F12 The transaction was executed in multiple trades ranging from $194.7000 to $195.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F13 Directly beneficially owned by Suma M. Krishnan, the spouse of the Reporting Person.
F14 The transaction was executed in multiple trades ranging from $195.8300 to $196.7600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F15 The transaction was executed in multiple trades ranging from $196.8650 to $197.8500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F16 The transaction was executed in multiple trades ranging from $197.8700 to $198.8600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F17 The transaction was executed in multiple trades ranging from $198.8700 to $199.8600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F18 The transaction was executed in multiple trades ranging from $199.8800 to $200.8700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F19 The transaction was executed in multiple trades ranging from $200.9800 to $201.9400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
F20 Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control.